Oxford Asset Management’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-113,798
| Closed | -$1.39M | – | 1661 |
|
|
2019
Q4 | $1.39M | Buy |
113,798
+72,064
| +173% | +$877K | 0.04% | 641 |
|
|
2019
Q3 | $482K | Buy |
+41,734
| New | +$482K | 0.01% | 1274 |
|
|
2019
Q1 | – | Sell |
-77,942
| Closed | -$1.18M | – | 2133 |
|
|
2018
Q4 | $1.18M | Buy |
77,942
+44,975
| +136% | +$683K | 0.03% | 776 |
|
|
2018
Q3 | $664K | Sell |
32,967
-77,637
| -70% | -$1.56M | 0.01% | 1186 |
|
|
2018
Q2 | $2.23M | Buy |
110,604
+36,923
| +50% | +$745K | 0.04% | 603 |
|
|
2018
Q1 | $1.49M | Sell |
73,681
-23,235
| -24% | -$468K | 0.03% | 735 |
|
|
2017
Q4 | $1.3M | Sell |
96,916
-5,244
| -5% | -$70.6K | 0.03% | 800 |
|
|
2017
Q3 | $1.87M | Sell |
102,160
-40,947
| -29% | -$751K | 0.04% | 648 |
|
|
2017
Q2 | $2.63M | Sell |
143,107
-56,761
| -28% | -$1.04M | 0.05% | 477 |
|
|
2017
Q1 | $4.51M | Buy |
199,868
+91,588
| +85% | +$2.07M | 0.11% | 172 |
|
|
2016
Q4 | $3.77M | Sell |
108,280
-133,886
| -55% | -$4.66M | 0.13% | 147 |
|
|
2016
Q3 | $5.94M | Buy |
242,166
+65,424
| +37% | +$1.6M | 0.18% | 132 |
|
|
2016
Q2 | $4.23M | Sell |
176,742
-45,347
| -20% | -$1.08M | 0.14% | 184 |
|
|
2016
Q1 | $5.2M | Buy |
222,089
+97,068
| +78% | +$2.27M | 0.15% | 153 |
|
|
2015
Q4 | $3.77M | Buy |
+125,021
| New | +$3.77M | 0.09% | 245 |
|